Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib

标题
Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib
作者
关键词
Positron emission tomography, Lung cancer, Tyrosine kinase inhibitor, EGFR wild-type, Metabolic tumor volume
出版物
LUNG CANCER
Volume 94, Issue -, Pages 81-87
出版商
Elsevier BV
发表日期
2016-02-09
DOI
10.1016/j.lungcan.2016.01.024

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started